[1]
W. . Rizwan, A. U. . Qureshi, M. N. . Rana, M. N. . Duggal, M. . . Sohaib, and M. . Sadiq, “Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan”, Annals KEMU, vol. 27, no. 4, pp. 515–522, Feb. 2022.